@article{0d8aa56bc14742e7b5f035c607e2addb,
title = "Health-Related Quality of Life With Pomalidomide + Dexamethasone + Daratumumab After Lenalidomide in Relapsed or Refractory Multiple Myeloma Patients",
author = "Donna Reece and Bahlis, \{Nizar J.\} and Samaras, \{Christy Joy\} and Michael Sebag and Jesus Berdeja and Siddhartha Ganguly and Jeffrey Matous and Kevin Song and Seet, \{Christopher S.\} and Giampaolo Talamo and Mirelis Acosta-Rivera and Michael Bar and Donald Quick and Bertrand Anz and Gustavo Fonseca and Amit Agarwal and Weiyuan Chung and Faiza Zafar and Siegel, \{David S.\}",
note = "Treatment of relapsed/refractory multiple myeloma (RRMM) is complex and requires evaluation of disease and patient factors to maximize efficacy and minimize toxicity. As therapeutic advances have improved survival in multiple myeloma, maintaining quality of life has become an important aspect of treatment.",
year = "2019",
month = oct,
day = "1",
doi = "10.1016/J.CLML.2019.09.457",
language = "American English",
volume = "19",
journal = "Clinical Lymphoma, Myeloma \& Leukemia",
number = "10",
}